We've upgraded our website. Accounts from our old site were not carried over, so please register again to sign in. Register now

Need help?WhatsApp +27 63 364 3825info@sapeptides.co.za

Free delivery on orders over R1

Sign in
Peptides

CBL-514 (a DYRK1B inhibitor - lipolysis drug) - 5mg

5MG per vial

Purity
97%+
Size
1 vial
Form
Powder

R2 000Excl. VAT

Or 4 interest-free payments withPayflex

Subcutaneous Fat Reduction. Visceral Fat Reduction

Sold out for now

Add it to your wishlist and we'll email you when it's back

  • Injectable peptides come with all the water you need and 10 free syringes
  • Door-to-door courier or Postnet to Postnet, anywhere in South Africa
  • Individually labelled and packed in heat-resistant material
  • Pay with Payflex or EFT
Questions about this product? Ask us on WhatsApp

Introduction

CBL-514 is an investigational, first-in-class small-molecule injectable drug developed designed to reduce localized subcutaneous and visceral fat without surgery.

Key Characteristics & Mechanism

* Mechanism of Action: Unlike traditional fat-dissolving agents or weight-loss drugs that shrink fat cells or cause tissue necrosis, CBL-514 acts as a DYRK1B inhibitor that selectively triggers apoptosis (programmed cell death) in adipocytes (fat cells).

* Target Areas: Developed for non-surgical localized fat reduction in larger body areas such as the abdomen, thighs, flanks, and submental/periumbilical regions, as well as conditions like cellulite and Dercum's disease (painful lipomas).

* Administration: Given via subcutaneous injection.

Clinical Trial Findings

* Subcutaneous Fat Reduction: Phase 2 clinical trials showed significant reductions in abdominal fat volume, with a high percentage of treated participants achieving reductions of 150 mL to over 300 mL in targeted areas (significantly outperforming placebo groups).

* Visceral Fat Reduction: Preliminary data also demonstrated an average reduction in deep visceral abdominal fat (~12% reduction at week 4 post-treatment).

Side effects

Side effects are generally mild-to-moderate and localized to the injection site (such as temporary swelling, redness, bruising, or pain), with no reports of skin necrosis, ulceration, or severe systemic side effects seen in older injection lipolysis methods.

Dosing Details - CBL-514

You inject 2.5ml water into the vial of CBL-514 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 50 (50ml) on the syringe each treatment, in the evening and inject it into the area you want affect, injection area covered is 1 cm sqaured, (sub cutaneous) at site of required fat loss.

How long will a vial last ?

A vial should last 5 uses.

For research use only. Not for human or animal consumption.